DiscoverX is now a part of Eurofins Pharma Discovery Services

Contact

log-in

About Us / Press Releases

Find a Product

About Us

News & Press Releases

9/5/2017

DiscoverX Customer Announcement

Eurofins Acquires DiscoverX

7/31/2017

Eurofins Expands its Offering and Footprint in Drug Discovery Services with the Acquisition of DiscoverX

Eurofins Acquires DiscoverX

4/10/2017

DiscoverX Partners with B’SYS GmbH to Expand SAFETYscan In Vitro Pharmacological Profiling Services

Announcing the partnership with B'SYS GmbH to expand SAFETYscan™ in vitro pharmacological profiling services

2/27/2017

Rapidly Screen Molecules for Novel Immuno-Oncology Therapeutics with Checkpoint Receptor Screening and Profiling Services

Introducing PathHunter^® iONCscan Services

9/19/2016

DiscoverX Launches Cell-Based Assays for Confirmation of Compound-Target Engagement in Drug Discovery

Announcing the InCELL Pulse™ target engagement platform

9/19/2016

DiscoverX Launches Services for Early Identification of Potential Drug Side Effects

Announcing the launch of the SAFETYscan™ in vitro pharmacological profiling services

6/28/2016

DiscoverX Launches Toolbox Products for GPCR β-Arrestin Cell Line and Cell-Based Assay Generation

Announcing PathHunter^® β-Arrestin Retroparticles

3/29/2016

DiscoverX Launches KILR™ Assay Platform for use in Cancer Immunotherapy Drug Development

Announcing the launch of the KILR™ Retropartices

2/29/2016

DiscoverX and the SGC Partner to Make an Annotated Collection of >600 Kinase Inhibitors Freely Available

DiscoverX partners with the Structural Genomics Consortium (SGC)

2/1/2016

Easily Measure Cancer Cell Death in a Co-Culture with KILR™ Assays from DiscoverX

Announcing the launch of the KILR™ Cytotoxicity Assay

Displaying results 1-10 (of 42)

|< < 1 - 2 - 3 - 4 - 5 > >|